Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo-Liang Deng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|September 13, 2002
Helical rosette nanotubes with tunable chiroptical propertiesHicham Fenniri, Bo-Liang Deng, Alexander E Ribbe
The Journal of Organic Chemistry|January 9, 2008
A regioselective approach to trisubstituted 2 (or 6)-arylaminopyrimidine-5-carbaldehydes and their application in the synthesis of structurally and electronically unique GlambdaC base precursorsRachel L Beingessner, Bo-Liang Deng, Phillip E Fanwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Entropically driven self-assembly of multichannel rosette nanotubesHicham Fenniri, Bo-Liang Deng, Alexander E Ribbe, et al.
Journal of Medicinal Chemistry|August 18, 2006
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituentsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitorsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
European Journal of Medicinal Chemistry|October 28, 2008
Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitorsBo-Liang Deng, Yujie Zhao, Tracy L Hartman, et al.
Journal of Medicinal Chemistry|September 7, 2007
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stabilityMatthew D Cullen, Bo-Liang Deng, Tracy L Hartman, et al.
Bioorganic & Medicinal Chemistry|December 3, 2005
Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole ringsBo-Liang Deng, Matthew D Cullen, Zhigang Zhou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|September 13, 2002
Helical rosette nanotubes with tunable chiroptical propertiesHicham Fenniri, Bo-Liang Deng, Alexander E Ribbe
The Journal of Organic Chemistry|January 9, 2008
A regioselective approach to trisubstituted 2 (or 6)-arylaminopyrimidine-5-carbaldehydes and their application in the synthesis of structurally and electronically unique GlambdaC base precursorsRachel L Beingessner, Bo-Liang Deng, Phillip E Fanwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Entropically driven self-assembly of multichannel rosette nanotubesHicham Fenniri, Bo-Liang Deng, Alexander E Ribbe, et al.
Journal of Medicinal Chemistry|August 18, 2006
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituentsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitorsBo-Liang Deng, Tracy L Hartman, Robert W Buckheit, et al.
European Journal of Medicinal Chemistry|October 28, 2008
Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitorsBo-Liang Deng, Yujie Zhao, Tracy L Hartman, et al.
Journal of Medicinal Chemistry|September 7, 2007
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stabilityMatthew D Cullen, Bo-Liang Deng, Tracy L Hartman, et al.
Bioorganic & Medicinal Chemistry|December 3, 2005
Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole ringsBo-Liang Deng, Matthew D Cullen, Zhigang Zhou, et al.
Pageof 1